Momenta Pharmaceuticals, Inc. (MNTA)

[semi_infinite]

"The model sucks."

The model doesn't take into account that branded companies will move fast enough to protect their franchise. Look at the ABBV IP protection barriers for Humira. It must have looked easy to penetrate at a distance. Even if it is penetrated, there will be multiple players. It seems only crumbs are left and even crumbs disappear in the case of Lovenox.